Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1400 of 2873 entries
View as:

rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin

Phase: N/A Priority: Normal
NCT ID: NCT00038012 Org: User:
Start: 07/23/99 End: 06/30/04 Due: 06/30/05

Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00493350 Org: User:
Start: 10/31/05 End: 12/31/07 Due: 12/31/08

Voraxaze for Delayed Methotrexate Clearance

Phase: N/A Priority: Normal
NCT ID: NCT00424645 Org: User:
Start: 01/31/07 End: 01/31/08 Due: 01/31/09

ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT05062317 Org: User:
Start: 04/26/22 End: 02/28/26 Due: 02/28/27

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01515566 Org: User:
Start: 04/30/12 End: 04/30/13 Due: 04/30/14

Malignant Pleural Effusion With ZD6474

Phase: N/A Priority: Normal
NCT ID: NCT00402896 Org: User:
Start: 10/31/06 End: 06/30/14 Due: 06/30/15

Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03068624 Org: User:
Start: 09/08/17 End: 07/31/25 Due: 07/31/26

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01094860 Org: User:
Start: 06/08/10 End: 08/09/18 Due: 08/09/19

FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib

Phase: N/A Priority: Normal
NCT ID: NCT01143779 Org: User:
Start: 06/30/10 End: 12/27/21 Due: 12/27/22

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002565 Org: User:
Start: 05/25/94 End: 02/05/07 Due: 02/05/08

Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT02269280 Org: User:
Start: 10/13/14 End: 07/25/24 Due: 07/25/25

Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00290511 Org: User:
Start: 06/29/04 End: 02/12/21 Due: 02/12/22

Open-Label Study of TPI 287 for Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01340729 Org: User:
Start: 09/30/13 End: - Due: -

Development of the MDASI-Spine Tumor Module

Phase: N/A Priority: Normal
NCT ID: NCT00430872 Org: User:
Start: 01/31/07 End: 07/31/08 Due: 07/31/09

Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT04870645 Org: User:
Start: 03/30/21 End: 08/29/23 Due: 08/29/24

Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01436227 Org: User:
Start: 01/17/12 End: 03/13/24 Due: 03/13/25

Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial

Phase: N/A Priority: Normal
NCT ID: NCT04789681 Org: User:
Start: 07/20/21 End: 12/31/25 Due: 12/31/26

Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT01198067 Org: User:
Start: 10/06/10 End: 04/30/25 Due: 04/30/26

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03164460 Org: User:
Start: 05/22/17 End: 05/31/25 Due: 05/31/26

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT04650178 Org: User:
Start: 05/26/20 End: 04/30/27 Due: 04/30/28

Valproic Acid and Bevacizumab in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00530907 Org: User:
Start: 06/30/07 End: 11/30/13 Due: 11/30/14

Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01372540 Org: User:
Start: 02/24/12 End: 05/16/19 Due: 05/16/20

Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT00386373 Org: User:
Start: 08/31/03 End: 10/31/07 Due: 10/31/08

Intraoperative Optical Imaging of Brain Function

Phase: N/A Priority: Normal
NCT ID: NCT00632437 Org: User:
Start: 02/29/08 End: 06/30/10 Due: 06/30/11

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00542373 Org: User:
Start: 08/27/07 End: 04/30/25 Due: 04/30/26